JPMorgan Chase Financial Co. LLC has announced a new offering of structured notes linked to the S&P 500 Futures Excess Return Index. This filing, made on November 12, 2026, is significant as it showcases the company’s continued efforts to diversify its financial products in a competitive market.
JPMorgan Chase Financial Co. LLC operates in the national commercial banks sector, focusing on providing a range of financial services. The company is incorporated in Delaware and has its business address at 383 Madison Avenue, New York, NY. The firm has been active in the financial markets, as evidenced by its recent filings, which include multiple offerings and pricing supplements.
The filing indicates the terms of the new notes, which have a minimum denomination of $1,000. The notes will be linked to the S&P 500 Futures Excess Return Index, with a pricing date set for November 24, 2026, and a maturity date of November 30, 2032. The offering includes an upside leverage factor of at least 2.12 and a barrier amount set at 60% of the initial value.
The filing states: "If the Final Value is greater than the Initial Value, your payment at maturity per $1,000 principal amount note will be calculated as follows: $1,000 + ($1,000 × Index Return × Upside Leverage Factor)."
This new offering may affect investors looking for structured products that provide exposure to the equity markets with defined risk parameters. The notes are subject to the credit risk of both JPMorgan Chase Financial Co. LLC and its parent company, JPMorgan Chase & Co., which guarantees the notes.
As for what’s next, the filing does not specify any further actions or upcoming votes related to this offering. Investors and market participants will be watching closely for more details as the pricing date approaches.
Read Next
Dominion Energy announces $1.2 billion senior notes issuance
Lakefront Biotherapeutics Launches €50 Million Share Buyback
Coca-Cola Europacific Partners Announces Share Buyback Details
Zenta Group announces $6.47 million at-the-market offering
MapLight Therapeutics Enters $100 Million Sales Agreement
Cyabra, Inc. Secures $15.6 Million in Private Placement










